Lungpacer News & Media
Stay up to date with the latest breakthroughs,
research, and company milestones
Sort by:
Lungpacer Announces New Category III CPT® Codes for AeroPace® Diaphragm Neurostimulation Therapy
July 22, 2026
Press Release
Lungpacer Medical Appoints Steven Pfanstiel as Chief Financial Officer
June 1, 2026
Press Release
Lungpacer Achieves Commercial Milestone as Leading U.S. Hospital Performs First AeroPace® Procedures to Help Patients Liberate from Mechanical Ventilation
December 8, 2025
Press Release
Lungpacer Medical Announces First Enrollments in STARI Trial of Next-Generation Neurostimulation Therapy
November 4, 2025
Press Release
Lungpacer Announces CMS NTAP Approval for AeroPace® System in FY2026 IPPS Final Rule
August 14, 2025
Press Release
Empowering Lung Recovery with Doug Evans of Lungpacer
July 15, 2025
News
After Tragedy, an Entrepreneur’s Triumph
June 26, 2025
News
American Journal of Respiratory and Critical Care Medicine Publishes Landmark Data on AeroPace® System’s Breakthrough Results in Ventilator Weaning
June 12, 2025
Press Release
Lungpacer announces 150th global patent for interventional neurostimulation technology portfolio
May 23, 2025
News
